Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Medical Informatics

Date Submitted: Mar 25, 2020
Date Accepted: Jul 16, 2020

The final, peer-reviewed published version of this preprint can be found here:

An Iterative Process for Identifying Pediatric Patients With Type 1 Diabetes: Retrospective Observational Study

Morris HL, Donahoo WT, Bruggeman B, Zimmerman C, Hiers P, Zhong VW, Schatz D

An Iterative Process for Identifying Pediatric Patients With Type 1 Diabetes: Retrospective Observational Study

JMIR Med Inform 2020;8(9):e18874

DOI: 10.2196/18874

PMID: 32886067

PMCID: 7501576

Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.

Identifying Pediatric Patients with Type 1 Diabetes: Computable Phenotyping using Electronic Health Records

  • Heather Lynne Morris; 
  • William Troy Donahoo; 
  • Brittany Bruggeman; 
  • Chelsea Zimmerman; 
  • Paul Hiers; 
  • Victor W Zhong; 
  • Desmond Schatz

ABSTRACT

Background:

The burden of type 1 diabetes (T1D) in children youth is growing. However, the current approach for identifying pediatric T1D is costly, because it requires substantial manual efforts. The purpose of this study was to develop a computable phenotype for accurately and efficiently identifying T1D in youth.

Objective:

The objectivel of the project was to use a set of criteria known to be associated with pediatric patients with Type 1 diabetes, and apply this knowledge in the form of a phenotype to query the electronic health record and identify members who met the criteria.

Methods:

This retrospective study utilized a dataset from the University of Florida Health Integrated Data Repository (IDR) to identify 300 patients <18 years of age with T1DM, T2DM, or were healthy based upon a developed computable phenotype. Three endocrinology residents/fellows manually reviewed medical records of all probable cases to validate diabetes status and type. This refined computable phenotype was then used to identify all cases of T1DM and T2DM in the OneFlorida Clinical Research Consortium.

Results:

A total of 295 electronic health records were manually reviewed. A total of 126 cases were found to have type 1 diabetes, 35 with type 2, and 130 with no diagnosis. After running analyses, the positive predictive value was 94.7 percent, the sensitivity was 96.9 percent, specificity was 95.8 percent, and the negative predictive value was 97.6 percent. Overall, the computable phenotype was found to be an accurate and sensitive method to pinpoint pediatric patients with type 1 diabetes.

Conclusions:

We developed a computable phenotype for identifying T1D correctly and efficiently. The computable phenotype that was developed will enable researchers to identify a population accurately and cost-effectively. As such, this will vastly improve the ease of identifying patients for future intervention studies.


 Citation

Please cite as:

Morris HL, Donahoo WT, Bruggeman B, Zimmerman C, Hiers P, Zhong VW, Schatz D

An Iterative Process for Identifying Pediatric Patients With Type 1 Diabetes: Retrospective Observational Study

JMIR Med Inform 2020;8(9):e18874

DOI: 10.2196/18874

PMID: 32886067

PMCID: 7501576

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.